Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
CNS Drugs|June 9, 2004
New formulations of existing antidepressants: advantages in the management of depressionTrevor R Norman, James S OlverNeuropsychiatric Disease and Treatment|April 2, 2009
Duloxetine in the treatment of generalized anxiety disorderTrevor R Norman, James S OlverDrug Design, Development and Therapy|April 7, 2010
Continuation treatment of major depressive disorder: is there a case for duloxetine?Trevor R Norman, James S OlverExpert Opinion on Pharmacotherapy|March 12, 2021
Desvenlafaxine in the treatment of major depression: an updated overviewTrevor R Norman, James S OlverExpert Opinion on Pharmacotherapy|February 14, 2019
Agomelatine for depression: expanding the horizons?Trevor R Norman, James S OlverExpert Review of Neurotherapeutics|October 22, 2011
Duloxetine in the acute and continuation treatment of major depressive disorderLanny Bochsler, James S Olver, Trevor R NormanHuman Psychopharmacology|January 13, 2004
The treatment of depression with different formulations of venlafaxine: a comparative analysisJames S Olver, Graham D Burrows, Trevor R NormanNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 21, 2005
Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteersKaren T Hallam, James S Olver, Trevor R NormanHuman Psychopharmacology|July 29, 2009
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonistDanijela Piskulić, James S Olver, Paul Maruff, et al.Psychiatry Research|February 13, 2007
Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature reviewDanijela Piskulic, James S Olver, Trevor R Norman, et al.Pageof 5